|
|
Article: Funding Research Grant Announced for Herpes Simplex Vaccine
- Article from:
- Vaccine Weekly
- Article date:
- June 8, 1998
CopyrightCOPYRIGHT 1998 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Cel-Sci Corp., Alexandria, Virginia, announced the receipt of a phase I $100,000 research grant to fund further animal studies with its herpes simplex vaccine.
The grant was given pursuant to the Small Business Innovation Research Program (SBIR) of the U.S. National Institute of Allergy and Infectious Diseases (NIAID).
Daniel Zimmerman, Cel-Sci Corp., said, "We have shown protection against herpes simplex infectivity in animals. Our ultimate goal is to bring to market a preventive and therapeutic vaccine against herpes simplex infection in humans for which there is no approved vaccine or curative treatment available."
The vaccine is based upon the ...